Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 23-32

  Rowell, Nicholas P ^a  

^a MAIDSTONE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Locoregional relapse; Mastectomy; Node negative; Radiotherapy; Risk factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; LEVAMISOLE; METHOTREXATE; TAMOXIFEN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW; THORAX WALL; TUMOR VOLUME;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; THORACIC WALL;

EID: 62549124985     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.09.026     Document Type: Review

References (54)

1. Goldhirsch A., Wood W.C., Gelber R.D., et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18 (2007) 1133-1144
2. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
3. Truong P.T., Olivotto I.A., Whelan T.J., and Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. Can Med Assoc J 170 (2004) 1263-1273
4. Cuzick J., Stewart H., Peto R., et al. Overview of randomised trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71 (1987) 15-29
5. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
6. Olivotto I.A., and Truong P.T. Postmastectomy radiation therapy: who needs it?. J Clin Oncol 22 (2004) 4237-4239
7. Barton M. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear-quadratic equation. Int J Radiat Oncol Biol Phys 31 (1995) 371-378
8. Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of iso-effect relationships. In: Basic clinical radiobiology. 2nd ed. London: Arnold; 1997.
9. Gelman R., Gelber R., Henderson I.C., Coleman C.N., and Harris J.R. Improved methodology for analysing local and distant recurrence. J Clin Oncol 8 (1990) 548-555
10. Gebski V., Lagleva M., Keech A., Simes J., and Langlands A.O. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Nat Cancer Inst 98 (2006) 26-38
11. Overgaard M. Overview of randomised trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. Semin Radiat Oncol 9 (1999) 292-299
12. Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
13. Høst H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 (1986) 727-732
14. Friedl W., Scheurlen H.R., and Henningsen B. The value of radiotherapy after modified radical mastectomy. 10-year results of the Heidelberg study. Dtsch Med Wochenschr 108 (1983) 325-330
15. Tennvall-Nittby L., Tengrup I., and Landberg T. The total incidence of loco-regional recurrence in a randomised trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 32 (1993) 641-646
16. Killander F., Anderson H., Rydén S., et al. Radiotherapy and tamoxifen after mastectomy in postmenopausal women - 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I. Eur J Cancer 43 (2007) 2100-2108
17. Arriagada R., Rutqvist L.E., Mattsson A., Kramar A., and Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13 (1995) 2869-2878
18. Klefström P., Gröhn P., Heinonen E., Holsti L., and Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 60 (1987) 936-942
19. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New Engl J Med 337 (1997) 949-955
20. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
21. Rutqvist L.E., Pettersson D., and Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long term follow-up of a randomised clinical trial. Radiother Oncol 26 (1993) 100-104
22. Ahlborn T.N., Gump F.E., Bodian C., Habif D.V., and Kister S. Tumour to fascia margin as a factor in local recurrence after modified radical mastectomy. Surg Gynecol Obst 166 (1988) 523-526
23. Beenken S.W., Urist M.M., Zhang Y., et al. Axillary lymph node status, but not tumour size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 5 (2003) 732-739
24. Buchanan C.L., Dorn P.L., Fey J., et al. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg 203 (2006) 469-474
25. Ernst M.F., Voogd A.C., Coebergh J.W.W., Poortmans P.M., and Roukema J.A. Using loco-regional recurrence as an indictor of the quality of breast cancer treatment. Eur J Cancer 40 (2004) 487-493
26. Jager J.J., Volovics L., Schouten L.J., et al. Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 50 (1999) 267-275
27. Jagsi R., Raad R.A., Goldberg S., et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 62 (2005) 1035-1039
28. Janni W., Dimpfl T., Braun S., et al. Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival. Int J Radiat Oncol Biol Phys 48 (2000) 967-975
29. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18 (2000) 2817-2827
30. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomised trials. J Clin Oncol 19 (2001) 1688-1697
31. Wallgren A., Bonetti M., Gelber R.D., et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group trials I through VII. J Clin Oncol 21 (2003) 1205-1213
32. Karlsson P., Cole B.F., Price K.N., et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol 25 (2007) 2019-2026
33. Yau TK, Chang TY, Soong S, et al. Postmastectomy locoregional recurrence in Hong Kong: low risk patients without radiotherapy have more failures than intermediate risk patients with radiotherapy. Presented at 30th San Antonio Breast Cancer Symposium; 2007 [Abstract 4094].
34. Yildrim E., and Berberoglu U. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumour who may benefit from postmastectomy radiotherapy be identified?. Int J Radiat Oncol Biol Phys 68 (2007) 1024-1029
35. Taghian A.G., Jeong J.H., Mamounas E.P., et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumours 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. J Clin Oncol 24 (2006) 3927-3932
36. Floyd S.R., Buchholz T.A., Haffty B.G., et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumours 5 cm and larger. Int J Radiat Oncol Biol Phys 66 (2006) 358-364
37. Helintö M., Blomqvist C., Heikkilä P., and Joensuu H. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?. Radiother Oncol 52 (1999) 213-217
38. Mok T.S.K., Kwan W.H., Yeo W.M., et al. Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer. Radiother Oncol 54 (2000) 201-208
39. Aksu G., Kucucuk S., Fayda M., et al. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease. Eur J Surg Oncol 33 (2007) 285-293
40. Truong P.T., Olivotto I.A., Speers C.H., Wai E.S., Berthelet E., and Kader H.A. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int J Radiat Oncol Biol Phys 58 (2004) 797-804
41. Truong P.T., Yong C.M., Abnousi F., et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg 200 (2005) 912-921
42. Freedman G.M., Fowble B.L., Hanlon A.L., et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 41 (1998) 599-605
43. Mentzer S.J., Osteen R.T., and Wilson R.E. Local recurrence and the deep resection margin in carcinoma of the breast. Surg Gynecol Obst 163 (1986) 513-517
44. Højris I., Overgaard M., Christensen J.J., et al. Morbidity and mortality of ischaemic heart disease in high-risk breast cancer patients after adjuvant post-mastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet 354 (1999) 1425-1430
45. Van de Steene J., Vinh-Hung V., Cutuli B., and Storme G. Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol 72 (2004) 35-43
46. Stewart L.A., and Parmar M.K. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 341 (1993) 418-422
47. Nielsen H.M., Overgaard M., Grau C., Jensen A.R., and Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer - risk and prognosis. An analysis of patients from the DBCG 82 b&c randomisation trials. Radiother Oncol 79 (2006) 147-155
48. Early Breast Cancer Trialists' Collaborative Group. Chemotherapy and hormonal therapy for early breast cancer: effects of recurrence and 15-year survival in an overview of the randomised trials. Lancet 2005;365:1687-717.
49. Kaufman E.L., Jacobson J.S., Hershman D.L., Desai M., and Neugut A.I. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 26 (2008) 392-398
50. Giordano S.H., Kuo Y.F., Freeman J.L., Buchholz T.A., Hortobagyi G.N., and Goodwin J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97 (2005) 419-424
51. Katz A., Strom E.A., Buchholz T.A., et al. The influence of pathologic tumour characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50 (2001) 735-742
52. Wilson CB, Haba Y, Wishart GC. The identification of patients for post-mastectomy radiotherapy using the Cambridge index: audit of a prospective series. Presented at 30th San Antonio Breast Cancer Symposium; 2007 [Abstract 4093].
53. Kunkler I.H., Canney P., van Tienhoven G., et al. Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol 20 (2008) 31-34
54. Available from: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Speaker?&spk=Darby%2C+Sarah+%5Bfau%5D.